CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high‐risk disease
Open Access
- 1 April 2003
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 121 (1), 36-43
- https://doi.org/10.1046/j.1365-2141.2003.04260.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 36 references indexed in Scilit:
- Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridizationLeukemia, 2001
- CD27: a memory B-cell markerImmunology Today, 2000
- Plasma Cell Generation from B-Lymphocytes via CD27/CD70 InteractionLeukemia & Lymphoma, 1999
- A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1British Journal of Haematology, 1996
- CD27–CD70 Interaction: Unravelling its Implication in Normal and Neoplastic B-Cell GrowthLeukemia & Lymphoma, 1995
- CD27: marker and mediator of T-cell activation?Immunology Today, 1994
- CD27 expression by a distinct subpopulation of human B lymphocytesEuropean Journal of Immunology, 1990
- Characterization of a new IgGλ myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myelomaBritish Journal of Haematology, 1990
- Two distinct human myeloma cell lines originating from one patient with myelomaInternational Journal of Cancer, 1985
- HUMAN PLASMACYTOMA WITH AN UNUSUAL KARYOTYPE GROWING IN VITRO AND PRODUCING LIGHT-CHAIN IMMUNOGLOBULINThe Lancet, 1982